API
< Back to all clusters
[BUSINESS] · United Kingdom, United States · 3 sources

started · updated

Avacta enters Capital Access Window for equity fundraising

Avacta has entered the AIM Capital Access Window ahead of a proposed equity fundraising. The company initiated a voluntary temporary pause in AIM trading on September 30 to facilitate discussions with a wider range of investors and establish pricing for the raise.

The proceeds from the equity raise are intended to extend Avacta’s cash runway beyond early Q1 2027. Specifically, the funds will support the development of AVA6103, the continuation of the AVA6000 programme, and the advancement of AVA6207 toward Phase 1 trials. The company has not yet disclosed the total amount to be raised, the number of new shares, or the expected dilution.

Entities

Arvinas, Inc. · Avacta · Nasdaq · Pfizer